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Abstract
Background: Shock wave lithotripsy (SWL) is a noninvasive, safe, and efficient treatment option for ureteral stones.
Depending on stone location and size, the overall stone-free rate (SFR) varies significantly. Failure of stone
disintegration results in unnecessary exposure to shock waves and radiation and requires alternative treatment
procedures, which increases medical costs. It is therefore important to identify predictors of treatment success or
failure in patients who are potential candidates for SWL before treatment. Nowadays, noncontrast computed
tomography (NCCT) provides reliable information on stone location, size, number, and total stone burden. The
impact of additional information provided by NCCT, such as skin-to-stone distance (SSD) and mean attenuation
value (MAV), on stone fragmentation in ureteral stone disease has hardly been investigated separately so far.
Thus, the objective of this study was to assess the influence of stone attenuation, SSD and body mass index (BMI)
on the outcome of SWL in ureteral stones.
Methods: We reviewed the medical records of 104 patients (80 men, 24 women) with ureteral stone disease treated
consecutively at our institution with SWL between 2010 and 2013. MAV in Hounsfield Units (HU) and SSD were
determined by analyzing noncontrast computed tomography images. Outcome of SWL was defined as successful
(visible stone fragmentation on kidney, ureter, and bladder film (KUB)) or failed (absent fragmentation on KUB).
Results: Overall success of SWL was 50 % (52 patients). Median stone attenuation was 956.9 HU (range 495–1210.8) in
the group with successful disintegration and 944.6 (range 237–1302) in the patients who had absent or insufficient
fragmentation. Median SSD was 125 mm (range 81–165 mm) in the group treated successfully and 141 mm (range
108–172 mm) in the patients with treatment failure. Unlike MAV (p = 0.37), SSD (p < 0.001) and BMI (p = 0.008)
significantly correlated with treatment outcome.
Conclusion: The choice of treatment for ureteral stones should be based on stone location and size as considered in
the AUA and EAU guidelines on urinary stone disease. In ambiguous cases, SSD and BMI can be used to assist in the
decision. In this study, MAV showed no correlation with fragmentation rate of SWL.
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Background
Shock wave lithotripsy (SWL) is a noninvasive, safe, and
efficient treatment option for ureteral stones. Depending
on stone location and size, the overall stone-free rate
(SFR) varies significantly, leading to corresponding recom-
mendations in the guidelines of the American Urological
Association and the European Association of Urology: For
proximal ureteral stones <10 mm, SWL has a higher SFR
than ureterorenoscopy (URS), while URS seems to be
superior for stones >10 mm. For mid-ureteral stones, URS
appears to be superior, with statistical limitations, because
fewer patients have been investigated. For distal stones
>10 mm, URS is the treatment of choice, while SWL and
URS are options for small stones [1, 2]. Failure of stone
disintegration results in unnecessary exposure to shock
waves and radiation, further patient suffering, and requires
alternative treatment procedures, which increases medical
costs [3]. It is therefore important to identify predictors of
treatment success or failure in patients who are potential
candidates for SWL before treatment.
Radiographic assessment of the stone is required to de-
cide on the best treatment. Nowadays, noncontrast com-
puted tomography (NCCT) provides reliable information
on stone location, size, number, and total stone burden,
and is therefore recommended as the standard diagnostic
tool in urinary stone disease [3, 4]. Moreover, several
studies have shown an impact of mean attenuation value
(MAV) on treatment success of SWL in kidney stones,
leading to corresponding guideline recommendations
[1, 2]. Despite the widespread use of NCCT, however,
the impact of additional information provided by
NCCT, such as skin-to-stone distance (SSD) and MAV,
on stone fragmentation in ureteral stone disease has
hardly been investigated separately so far [5–8]. More-
over, as limiting factors, three of the four studies
reported on so far covered only one SWL session
regardless of whether disintegration occurred or not,
and treatment success was analyzed in all four studies
at the earliest 2 weeks after SWL. The study by Ng et al.
also included only proximal ureteral stones, and no
real-time fluoroscopic screening was performed during
treatment [7].
Thus, the objective of this study was to determine how
additional information provided by NCCT and patient’s
physical constitution might influence fragmentation rate
of SWL in ureteral stone disease.
Table 1 shows a summary of the literature.
Methods
One hundred four patients treated consecutively with
SWL for distal and proximal ureteral stones in our
department between January 2010 and December 2013
were included in this retrospective study. Data analysis
was conducted according to the declaration of Helsinki
and approved by the Local Ethics Committee of St.
Gallen (EKSG 15/055). Written informed consent for
data analysis was obtained. NCCT was performed before
treatment using a multidetector row helical CT scanner
(Siemens, Definition Flash, Forchheim, Germany) with
30–460 mA, 120 kV and 2 mm collimation in every pa-
tient. As suggested in a study by Eisner et al. [9], stone size
and Hounsfield Unit (HU) measurements were obtained
in a standard bone window (window width-1,120 and win-
dow level-300). The image with the largest stone diameter
was used to define maximum stone size. MAV was
obtained by measuring the mean HU of defined regions of
interest just smaller than the stone in magnified images
without including adjacent soft tissue on each slice of the
axial planes (Fig. 1). SSD was calculated as described by El
Nahas et al. [3] and the distances at 0°, 45° and 90° were
measured using radiographic calipers (Fig. 2). The average
was calculated as the SSD. The measurements were per-
formed analogous in prone position when targeting pelvic
stones. The SSD was also measured and evaluated at an
angle of 90° separately, as this seems to be the most im-
portant angle in the setting of the SLX-F2 (Storz Medical,
Tägerwilen, Switzerland) which was used to perform SWL
under sedoanalgesia.
If tolerated by the patient, up to 4,000 shocks (60–90/
min) with an energy level of up to 8 according to the
manufacturer’s scale were delivered during each SWL
session. The energy level 8 corresponded to 16.4 kV with
the precise focus and 12.8 kV with the extended focus.
In patients with pain resistant to analgesic treatment,
the energy and number of shocks were reduced accord-
ing to the patient’s tolerance. Stones were targeted and
fragmentation was monitored by biplanar fluoroscopy at
regular intervals during treatment.
Patients were further evaluated by kidney, ureter, and
bladder (KUB) film, renal ultrasound, and sieving of
urine to assess fragmentation, the presence of renal dila-
tation and expulsion of ureteral stones the day after the
respective session. In cases of missing or inadequate
disintegration in KUB, SWL was repeated once or twice
at intervals of 1 day. The clinical outcome was defined
as successful (visible stone fragmentation on KUB) or
failed (absent fragmentation on KUB) immediately after
the last SWL session.
The correlation with and influence of a range of
baseline characteristics on treatment outcome of SWL
was examined: patient’s age, gender, weight, and BMI;
stone location and volume, MAV, SSD; use of alpha
blockers; presence of ureteral stents. Both univariate
(chi-square or Mann–Whitney U-tests for dichotomous
or continuous variables) and multivariate (binary logistic
regression) analyses were performed to define significant
factors. ROC curves were used for the determination of
the best cut-off values. All tests were two-sided and a
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Table 1 Review of the literature
Prediction of successful disintegration/treatment
References Year Stone location n All/Renal/Ureteral Mean attenuation value (MAV) All/Renal/Ureter SSD All/Renal/Ureter BMI All/Renal/Ureter Cut off MAV/SSD/BMI
Joseph et al. [14] 2002 Renal 30/30/- Yes/Yes/- -/-/- No/No/- Renal: 950 HU/-/-
Pareek et al. [6] 2003 Renal and ureteral 50/20/30 Yes/Yes/Yes -/-/- No/-/- Ureteral: 900 HU/-/-
Wang et al. [15] 2005 Renal 80/80/- Yes/Yes/- -/-/- -/-/- Renal: 900HU/-/-
Gupta et al. [16] 2005 Renal and proximal ureter 108/89/19 Yes/-/- -/-/- -/-/- All: 750 HU/-/-
Yoshida et al. [17] 2006 Renal and proximal ureter 56/25/31 Yes/-/- -/-/- -/-/- -/-/-
El Nahas et al. [3] 2007 Renal 120/120/- Yes/Yes/- Yes/Yes/- Yes/Yes/- Renal: 1000HU/-/-
Perks et al. [11] 2008 Renal 111/111/- Yes/Yes/- Yes/Yes/- No/No/- Renal: 900HU/9 cm/-
Ng et al. [7] 2009 Proximal ureter 94/-/94 Yes/-/Yes Yes/-/Yes No/-/No Renal:593 HU/9.2 cm/-
Patel et al. [10] 2009 Renal 83/83/- No/No/- Yes/Yes/- -/-/- Renal: −/10 cm/-
Wiesenthal et al. [5] 2010 Renal and ureteral 422/218/204 Yes/Yes/Yes Yes/Yes/Yes Yes/No/Yes All: 900 HU/ 11 cm/-
Park et al. [12] 2010 Renal 115/115/- Yes/Yes/- No/-/- -/-/- Renal: 863 HU/-/-
Shah et al. [18] 2010 Renal and proximal ureter 99/71/28 Yes/-/- -/-/- -/-/- -/-/-
Tanaka et al. [13] 2013 Renal and ureteral 75/27/48 Yes/-/- No/-/- No/-/- All: 780 HU/-/-
Celik et al. [8] 2015 Renal and ureteral 254/123/131 Yes/Yes/Yes -/Yes/ -/Yes/- Renal: 750 HU/-/-













Fig. 2 Skin-to-stone distance (SSD) was calculated by the measuring distances from Stone-to-skin at 0°, 45°, and 90° using radiographic calipers
Fig. 1 Defined regions of interest just smaller than the stone without including adjacent soft tissue
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p-value of <0.05 was necessary to reject the null-
hypothesis. Statistical analyses were performed using
IBM SPSS Statistics Version 22 (IBM Corp., New York,
U.S.A.).
Results
A total of 104 consecutive patients were included (24
women, 80 men), median age was 45.5 years (range
19–80 years). Median largest diameter of stones was
6 mm (range 2–15 mm) and median MAV 949.3 HU
(range 237–1302 HU).
The stones were located in the proximal ureter in 73
(70.2 %) patients and the distal ureter in 31 (29.8 %).
Median BMI was 26.2 (range 17.4–37.0), median SSD
(0°/45°/90°) 131.5 mm (range 81–172 mm) and median
SSD (90°) 119 mm (range 76–161 mm).
Stone fragmentation was visible in 52 (50 %) patients
and was not visible in the remaining patients, of whom 49
(94.2 %) needed further treatment: 43 (82.7 %) by URS, 4
(7.7 %) by ureteral stent insertion, and 2 (3.8 %) by further
cycles of SWL. The three patients who needed no further
treatment showed spontaneous stone passage during the
treatment with SWL without stone disintegration.
Of the 52 patients who showed good stone fragmenta-
tion, 13 (25 %) needed further treatment by URS (8 pa-
tients, 15.4 %,), ureteral stent insertion (1 patient, 1.9 %)
or further cycles of SWL (4 patients, 7.7 %) because of
impacted fragments or distal steinstrasse.
Median MAV was 956.9 HU (range 495–1210.8 HU)
in patients with good stone fragmentation and was 944.6
HU (range 237–1302 HU) in patients showing no stone
fragmentation and requiring further treatment. In uni-
variate analysis, MAV showed no correlation with stone
fragmentation (p = 0.373).
Median BMI, SSD (0°/45°/90°) and SSD (90°) in patients
with good stone fragmentation were 25.5 (range 17.4–
35.0), 125 mm (range 81–165 mm) and 114.5 mm (range
76–159 mm). In patients without stone fragmentation,
median BMI, SSD (0°/45°/90°) and SSD (90°) were 27.1
(range 21.1–37.0), 141 mm (range 108–172 mm) and 130
(range 85–161). In univariate analysis, BMI (p = 0.008),
SSD (0°/45°/90°) (p < 0.001) and SSD (90°) (p < 0.001)
significantly correlated with stone fragmentation.
In addition, maximum energy delivered showed a signifi-
cant correlation with disintegration outcome (p = 0.015).
Median energy level was 6 (range 4–8) in patients with
good stone fragmentation and 6.4 (range 5–8) in patients
with no stone fragmentation.
The results of univariate analyses are summarized in
Table 2.
According to multivariate analyses, SSD (90°) was a
significant predictor for disintegration failure (regression
coefficient: −0.046, standard error: 0.013, odds ratio
0.955, 95 % confidence interval: 0.930–0.980, p-value <
0.001). Moreover, maximum delivered energy tended to
be lower in patients with successful disintegration than
Table 2 Results of univariate analysis
Characteristic Successful disintegration Unsuccessful disintegration p-value
Number of patients (%) 52 (50 %) 52 (50 %) -
Age, years (median, range) 43.5 (19–80) 47.5 (22–77) 0.136
Gender, M/F (N/%) 35 (67.3 %)/17 (32.7 %) 45 (86.5 %)/7 (13.5 %) 0.035
Weight, kg (median, range) 73 (49–116) 85 (58–120) <0.001
BMI, kg/m2 (median, range) 25.5 (17.4–35.0) 27.1 (21.6–37.0) 0.008
Skin-to-stone distance, mm, mean of 0°, 45° and 90° (median, range) 125 (81–165) 141 (108–172) <0.001
Skin-to-stone distance, mm, 90° (median, range) 114.5 (76–159) 130 (85–161) <0.001
Mean attenuation value, HU (median, range) 956.9 (495–1210.8) 944.6 (237–1302) 0.373
Stone size, mm (median, range) 7 (3–15) 6 (2–12) 0.071
Location, proximal/distal (N, %) 36 (69.2 %)/16 (30.8 %) 37 (71.2 %)/15 (28.8 %) 1.000
SWL cycles (median, range) 2 (1–3) 2 (1–3) 0.786
Number of shockwaves (median, range) 8000 (1000–12000) 8000 (3000–14000) 0.583
Power/Intensity Level (median, range) 6 (4–8) 6.4 (5–8) 0.015
Ureteral stent in place (N, %) 15 (28.8 %) 13 (25 %) 0.825
Alpha-blocker (N, %) 42 (80.8 %) 38 (73.1 %) 0.486
Secondary procedures
URS (N, %) 8 (15.4 %) 43 (82.7 %) -
Ureteral stent (N, %) 1 (1.9 %) 4 (7.7 %) -
SWL (N, %) 4 (7.7 %) 2 (3.8 %) -
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in patients with disintegration failure without reaching
statistical significance (regression coefficient: −0.528,
standard error: 0.272, odds ratio 0.590, 95 % confidence
interval: 0.346–1.004, p-value < 0.052). Weight and BMI
of the patient were not included in the multivariate
analysis because of multicollinearity with SSD.
The ROC curves for different parameters were analyzed
to find the optimum cut-off values to predict disintegra-
tion failure (Fig. 3). The optimum cut-off point for SSD
(90°) would be >11.9 cm (sensitivity 65.4 %, specificity
65.3 %), for patient weight >82.5 kg (sensitivity 65.4 %,
specificity 71.4 %), and for BMI >25.9 kg/m2 (sensitivity
69.2 %, specifity 55.1 %).
Discussion
The results of this study show that SSD and BMI are sig-
nificant predictors of the outcome of SWL. As described
earlier by Patel et al. for kidney stones [10], we found no
significant association between MAV and fragmentation
rate of SWL for ureteral stones.
The use of NCCT for diagnosis of ureteral stones is
well established and a common practice worldwide
[7]. The method of measuring SSD in NCCT has been
well described in the literature and there are only
marginal differences between studies with regard to
the method [3, 5–7, 10–13].
The method for determining MAV has been described
inconsistently, however. For example, Joseph et al. [14]
used a calculous pixel map of 100 attenuation values in
a 10 x 10 matrix in unenhanced axial NCCT section,
while Wiesenthal et al. [5] measured attenuation values
using bone windows on the magnified, axial image of the
stone in the maximum diameter where the elliptical re-
gion of interest incorporated the largest cross-sectional
area of stone without including adjacent soft tissue. In
our study, we determined MAV by measuring the mean
HU of defined regions of interest just smaller than the
stone in magnified images without including adjacent
soft tissue on each slice of the axial planes (Fig. 1) with a
standard bone window (window width-1,120 and win-
dow level-300) as suggested in the study by Eisner et al.
[9]. We believe that this is the most accurate method of
determining MAV. The inconsistent methods used in
the literature might also explain the differing results that
have been reported, so far (Table 2). In our opinion,
image magnification for MAV measurement is very im-
portant because accurate stone margins can be identified
using only adequately magnified images (Fig. 1). Thus,
inclusion of adjacent soft tissue into measurement can
be avoided. In addition, we measured all available slices
of stones in axial planes to calculate MAV, which might
prevent assumption of too high or low MAVs, as stones
often consist of different components. The method of
measuring MAV should be standardized to allow com-
parison of different datasets.
Concerning MAV, cut-off values between 750 and 1000
HU for renal calculi and between 750 and 900 HU in
studies examining mixed ureteral and renal stones have
Fig. 3 ROC curves
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been suggested as predictors of SWL failure (Table 2).
However, separate examination of cut-off values for ur-
eteral stones has only been performed in two studies:
Pareek et al. [6] suggested 900 HU as the cut-off value
in their study of 30 ureteral stones, and Ng et al. [7]
defined a very different threshold of 593 HU as a
potential predictor of treatment success in a study in
94 patients with upper ureteral stones. Our study failed
to show an association between MAV and the dis-
integration of ureteral stones using SWL.
SSD has been shown to be a significant predictor of
the outcome of SWL in different studies on renal stones.
The findings for BMI, however, have been inconsistent
as illustrated in Table 2.
Only two studies have analyzed SSD as a predictor of
SWL treatment success in ureteral stones separately [5, 7]
and both showed that SSD was a significant predictor. In
this context, Ng et al. [7] suggested an SSD cut-off of
9.2 cm as a predictor for SWL failure, but they studied
only upper ureteral stones.
In our study, SSD (90°) emerged as an even stronger
predictor of treatment success or failure than mean SSD,
with a cut-off value of 11.9 cm for SWL failure, which
might be because we had patients in the almost straight
supine or prone position for treatment with SLX-F2.
Results for BMI as a predictor of stone disintegration
with SWL are also contradictory [5, 7]. In our study,
BMI and patient weight were significant predictors of
SWL outcome with cut-off values of 25.9 kg/m2 and
82.5 kg for SWL failure. Factors such as differences in
body fat distribution between men and women, and age
and race also have to be taken into consideration.
Possible limitations of our study are the retrospective
design and assessment of disintegration outcome by
KUB film and not by NCCT. Moreover, fragmentation
rate instead of SFR was chosen to define treatment suc-
cess or failure. We believed that this might represent the
stone’s response to SWL better, because SFR is influ-
enced by other factors that might interfere with stone
passage (e.g., ureteral diameter). On the other hand,
stone disintegration on KUB does not inevitably lead to
a successfully completed treatment.
Conclusions
The choice of treatment for ureteral stones should be
based on stone location and size as considered in the
AUA and EAU guidelines on urinary stone disease. Pa-
tient preference also has to be taken into consideration.
In ambiguous cases, SSD and BMI – in contrast to
MAV - can be easily used for additional guidance. In this
way, patients with a high risk of disintegration failure
could be educated more precisely, unnecessary exposure
to shock waves and radiation could be avoided and medical
costs could be reduced.
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film; ROC: Receiver operating characteristic.
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